IGC Pharma Inc
IGC Pharma Inc (IGC) Historical Volatility
IGC's 30 day historical volatility is 82.91%, in the 100th percentile of readings over the past year. This is a high percentile, meaning IGC Pharma Inc shares have swung far more than usual. IGC's 30 day implied volatility sits at 658.38%, with an IV Rank of 70.63%, leaving IV 575.47 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 20, 2026.
Read more
Tracking IGC historical volatility helps you see how much IGC Pharma Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, IGC's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor IGC 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. IGC's 30 day historical volatility, or IGC HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing IGC's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 20, 2026
As of Nov 20, 2026
As of Nov 20, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →